SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-051871
Filing Date
2023-04-28
Accepted
2023-04-28 06:02:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm231888d3_def14a.htm DEFA14A 12710
2 GRAPHIC tm231888d3_def14aimg001.jpg GRAPHIC 166889
3 GRAPHIC tm231888d3_def14aimg002.jpg GRAPHIC 145390
  Complete submission text file 0001104659-23-051871.txt   444037
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38129 | Film No.: 23859834
SIC: 2834 Pharmaceutical Preparations